Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Weinerman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
JAMA|June 9, 1978
Secondary malignant neoplasms in patients with Hodgkin's diseaseH Neufeld, B H Weinerman, S Kemel
Canadian Medical Association Journal|September 8, 1979
Treatment of polycythemia veraB K MacDougall, B H Weinerman, S Kemel
Cancer|September 15, 1981
Second malignancies in non-Hodgkin's lymphomaB K MacDougall, B H Weinerman, S Kemel
Canadian Journal of Surgery. Journal Canadien De Chirurgie|April 1, 1994
Late recurrence of testicular cancerJ M Embil, B H Weinerman, E A Pascoe
Canadian Medical Association Journal|April 1, 1982
Non-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapyL Deonarine, B H Weinerman, B K MacDougall, et al.
Cancer Treatment Reports|July 1, 1986
Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials GroupE A Eisenhauer, B H Weinerman, I Kerr, et al.
Journal of Surgical Oncology|March 1, 1986
Low-dose (diagnostic-like) x-ray as a cocarcinogen in mouse colon carcinomaB H Weinerman, K B Orr, L Lu, et al.
Canadian Medical Association Journal|August 12, 1978
Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disordersC Little, A M Shojania, P T Green, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group StudyB H Weinerman, E A Eisenhauer, J G Besner, et al.
The New England Journal of Medicine|December 9, 1993
Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphomaR M Meyer, I C Quirt, J R Skillings, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JAMA|June 9, 1978
Secondary malignant neoplasms in patients with Hodgkin's diseaseH Neufeld, B H Weinerman, S Kemel
Canadian Medical Association Journal|September 8, 1979
Treatment of polycythemia veraB K MacDougall, B H Weinerman, S Kemel
Cancer|September 15, 1981
Second malignancies in non-Hodgkin's lymphomaB K MacDougall, B H Weinerman, S Kemel
Canadian Journal of Surgery. Journal Canadien De Chirurgie|April 1, 1994
Late recurrence of testicular cancerJ M Embil, B H Weinerman, E A Pascoe
Canadian Medical Association Journal|April 1, 1982
Non-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapyL Deonarine, B H Weinerman, B K MacDougall, et al.
Cancer Treatment Reports|July 1, 1986
Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials GroupE A Eisenhauer, B H Weinerman, I Kerr, et al.
Journal of Surgical Oncology|March 1, 1986
Low-dose (diagnostic-like) x-ray as a cocarcinogen in mouse colon carcinomaB H Weinerman, K B Orr, L Lu, et al.
Canadian Medical Association Journal|August 12, 1978
Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disordersC Little, A M Shojania, P T Green, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group StudyB H Weinerman, E A Eisenhauer, J G Besner, et al.
The New England Journal of Medicine|December 9, 1993
Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphomaR M Meyer, I C Quirt, J R Skillings, et al.
Pageof 2